CURRENT RECOMMENDATIONS ON RISK STRATIFICATION AND SUDDEN CARDIAC DEATH PREVENTION IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY (BASED ON THE 2011 RECOMMENDATIONS BY THE AMERICAN COLLEGE OF CARDIOLOGY / AMERICAN HEART ASSOCIATION)

One of the clinical scenarios of hypertrophic cardiomyopathy (HCMP) is sudden cardiac death (SCD). The stratification of SCD risk is the key component of defining the therapeutic strategy in HCMP patients. Timely preventive treatment is the only life-saving intervention in patients with high SCD ris...

Full description

Saved in:
Bibliographic Details
Main Authors: E. V. Privalova, V. Yu. Kaplunova, N. V. Khabarova, G. A. Shakaryants, Yu. N. Belenkov
Format: Article
Language:Russian
Published: «SILICEA-POLIGRAF» LLC 2013-02-01
Series:Кардиоваскулярная терапия и профилактика
Subjects:
Online Access:https://cardiovascular.elpub.ru/jour/article/view/122
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849250368359235584
author E. V. Privalova
V. Yu. Kaplunova
N. V. Khabarova
G. A. Shakaryants
Yu. N. Belenkov
author_facet E. V. Privalova
V. Yu. Kaplunova
N. V. Khabarova
G. A. Shakaryants
Yu. N. Belenkov
author_sort E. V. Privalova
collection DOAJ
description One of the clinical scenarios of hypertrophic cardiomyopathy (HCMP) is sudden cardiac death (SCD). The stratification of SCD risk is the key component of defining the therapeutic strategy in HCMP patients. Timely preventive treatment is the only life-saving intervention in patients with high SCD risk. The available clinical evidence suggests that SCD risk stratification is an effective algorithm for determining the need for preventive treatment. The latter should be individualised, based on the risk levels in each patient.
format Article
id doaj-art-5d3f4a7ea6bf4cd5bc5db4ffa454fa02
institution Kabale University
issn 1728-8800
2619-0125
language Russian
publishDate 2013-02-01
publisher «SILICEA-POLIGRAF» LLC
record_format Article
series Кардиоваскулярная терапия и профилактика
spelling doaj-art-5d3f4a7ea6bf4cd5bc5db4ffa454fa022025-08-20T03:57:17Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252013-02-01121737910.15829/1728-8800-2013-1-73-79122CURRENT RECOMMENDATIONS ON RISK STRATIFICATION AND SUDDEN CARDIAC DEATH PREVENTION IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY (BASED ON THE 2011 RECOMMENDATIONS BY THE AMERICAN COLLEGE OF CARDIOLOGY / AMERICAN HEART ASSOCIATION)E. V. Privalova0V. Yu. Kaplunova1N. V. Khabarova2G. A. Shakaryants3Yu. N. Belenkov4I.M. Sechenov First Moscow State Medical UniversityMetabolic Syndrome Research Centre, MoscowMetabolic Syndrome Research Centre, MoscowI.M. Sechenov First Moscow State Medical UniversityI.M. Sechenov First Moscow State Medical UniversityOne of the clinical scenarios of hypertrophic cardiomyopathy (HCMP) is sudden cardiac death (SCD). The stratification of SCD risk is the key component of defining the therapeutic strategy in HCMP patients. Timely preventive treatment is the only life-saving intervention in patients with high SCD risk. The available clinical evidence suggests that SCD risk stratification is an effective algorithm for determining the need for preventive treatment. The latter should be individualised, based on the risk levels in each patient.https://cardiovascular.elpub.ru/jour/article/view/122hypertrophic cardiomyopathystratification of sudden cardiac death risksudden cardiac death risk preventioncardioverter defibrillator
spellingShingle E. V. Privalova
V. Yu. Kaplunova
N. V. Khabarova
G. A. Shakaryants
Yu. N. Belenkov
CURRENT RECOMMENDATIONS ON RISK STRATIFICATION AND SUDDEN CARDIAC DEATH PREVENTION IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY (BASED ON THE 2011 RECOMMENDATIONS BY THE AMERICAN COLLEGE OF CARDIOLOGY / AMERICAN HEART ASSOCIATION)
Кардиоваскулярная терапия и профилактика
hypertrophic cardiomyopathy
stratification of sudden cardiac death risk
sudden cardiac death risk prevention
cardioverter defibrillator
title CURRENT RECOMMENDATIONS ON RISK STRATIFICATION AND SUDDEN CARDIAC DEATH PREVENTION IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY (BASED ON THE 2011 RECOMMENDATIONS BY THE AMERICAN COLLEGE OF CARDIOLOGY / AMERICAN HEART ASSOCIATION)
title_full CURRENT RECOMMENDATIONS ON RISK STRATIFICATION AND SUDDEN CARDIAC DEATH PREVENTION IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY (BASED ON THE 2011 RECOMMENDATIONS BY THE AMERICAN COLLEGE OF CARDIOLOGY / AMERICAN HEART ASSOCIATION)
title_fullStr CURRENT RECOMMENDATIONS ON RISK STRATIFICATION AND SUDDEN CARDIAC DEATH PREVENTION IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY (BASED ON THE 2011 RECOMMENDATIONS BY THE AMERICAN COLLEGE OF CARDIOLOGY / AMERICAN HEART ASSOCIATION)
title_full_unstemmed CURRENT RECOMMENDATIONS ON RISK STRATIFICATION AND SUDDEN CARDIAC DEATH PREVENTION IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY (BASED ON THE 2011 RECOMMENDATIONS BY THE AMERICAN COLLEGE OF CARDIOLOGY / AMERICAN HEART ASSOCIATION)
title_short CURRENT RECOMMENDATIONS ON RISK STRATIFICATION AND SUDDEN CARDIAC DEATH PREVENTION IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY (BASED ON THE 2011 RECOMMENDATIONS BY THE AMERICAN COLLEGE OF CARDIOLOGY / AMERICAN HEART ASSOCIATION)
title_sort current recommendations on risk stratification and sudden cardiac death prevention in patients with hypertrophic cardiomyopathy based on the 2011 recommendations by the american college of cardiology american heart association
topic hypertrophic cardiomyopathy
stratification of sudden cardiac death risk
sudden cardiac death risk prevention
cardioverter defibrillator
url https://cardiovascular.elpub.ru/jour/article/view/122
work_keys_str_mv AT evprivalova currentrecommendationsonriskstratificationandsuddencardiacdeathpreventioninpatientswithhypertrophiccardiomyopathybasedonthe2011recommendationsbytheamericancollegeofcardiologyamericanheartassociation
AT vyukaplunova currentrecommendationsonriskstratificationandsuddencardiacdeathpreventioninpatientswithhypertrophiccardiomyopathybasedonthe2011recommendationsbytheamericancollegeofcardiologyamericanheartassociation
AT nvkhabarova currentrecommendationsonriskstratificationandsuddencardiacdeathpreventioninpatientswithhypertrophiccardiomyopathybasedonthe2011recommendationsbytheamericancollegeofcardiologyamericanheartassociation
AT gashakaryants currentrecommendationsonriskstratificationandsuddencardiacdeathpreventioninpatientswithhypertrophiccardiomyopathybasedonthe2011recommendationsbytheamericancollegeofcardiologyamericanheartassociation
AT yunbelenkov currentrecommendationsonriskstratificationandsuddencardiacdeathpreventioninpatientswithhypertrophiccardiomyopathybasedonthe2011recommendationsbytheamericancollegeofcardiologyamericanheartassociation